nodes	percent_of_prediction	percent_of_DWPC	metapath
Ixabepilone—TUBB4A—prostate gland—urinary bladder cancer	0.009	0.0391	CbGeAlD
Ixabepilone—TUBB2B—prostate gland—urinary bladder cancer	0.0087	0.0378	CbGeAlD
Ixabepilone—TUBB—prostate gland—urinary bladder cancer	0.00823	0.0357	CbGeAlD
Ixabepilone—TUBB2A—prostate gland—urinary bladder cancer	0.00819	0.0356	CbGeAlD
Ixabepilone—TUBB6—prostate gland—urinary bladder cancer	0.00807	0.0351	CbGeAlD
Ixabepilone—CYP3A4—urine—urinary bladder cancer	0.00803	0.0349	CbGeAlD
Ixabepilone—TUBB2B—seminal vesicle—urinary bladder cancer	0.00736	0.032	CbGeAlD
Ixabepilone—TUBB6—Zalcitabine—Gemcitabine—urinary bladder cancer	0.00702	0.581	CbGdCrCtD
Ixabepilone—TUBB4B—prostate gland—urinary bladder cancer	0.00702	0.0305	CbGeAlD
Ixabepilone—TUBB—seminal vesicle—urinary bladder cancer	0.00696	0.0302	CbGeAlD
Ixabepilone—TUBB2A—seminal vesicle—urinary bladder cancer	0.00692	0.0301	CbGeAlD
Ixabepilone—TUBB6—seminal vesicle—urinary bladder cancer	0.00683	0.0297	CbGeAlD
Ixabepilone—TUBB4A—renal system—urinary bladder cancer	0.00613	0.0266	CbGeAlD
Ixabepilone—TUBB4B—seminal vesicle—urinary bladder cancer	0.00594	0.0258	CbGeAlD
Ixabepilone—TUBB6—epithelium—urinary bladder cancer	0.00593	0.0258	CbGeAlD
Ixabepilone—TUBB2B—renal system—urinary bladder cancer	0.00593	0.0257	CbGeAlD
Ixabepilone—TUBB—smooth muscle tissue—urinary bladder cancer	0.00583	0.0253	CbGeAlD
Ixabepilone—TUBB2B—urethra—urinary bladder cancer	0.00582	0.0253	CbGeAlD
Ixabepilone—TUBB2A—smooth muscle tissue—urinary bladder cancer	0.0058	0.0252	CbGeAlD
Ixabepilone—TUBB6—smooth muscle tissue—urinary bladder cancer	0.00572	0.0248	CbGeAlD
Ixabepilone—TUBB—urethra—urinary bladder cancer	0.00551	0.0239	CbGeAlD
Ixabepilone—TUBB6—renal system—urinary bladder cancer	0.0055	0.0239	CbGeAlD
Ixabepilone—TUBB2A—urethra—urinary bladder cancer	0.00548	0.0238	CbGeAlD
Ixabepilone—TUBB6—urethra—urinary bladder cancer	0.00541	0.0235	CbGeAlD
Ixabepilone—TUBB4B—smooth muscle tissue—urinary bladder cancer	0.00497	0.0216	CbGeAlD
Ixabepilone—TUBB4A—female reproductive system—urinary bladder cancer	0.00491	0.0213	CbGeAlD
Ixabepilone—TUBB4B—renal system—urinary bladder cancer	0.00478	0.0208	CbGeAlD
Ixabepilone—TUBB2B—female reproductive system—urinary bladder cancer	0.00475	0.0206	CbGeAlD
Ixabepilone—TUBB4B—urethra—urinary bladder cancer	0.0047	0.0204	CbGeAlD
Ixabepilone—TUBB2A—female reproductive system—urinary bladder cancer	0.00447	0.0194	CbGeAlD
Ixabepilone—TUBB6—female reproductive system—urinary bladder cancer	0.00441	0.0191	CbGeAlD
Ixabepilone—TUBB2B—vagina—urinary bladder cancer	0.00429	0.0186	CbGeAlD
Ixabepilone—TUBB—vagina—urinary bladder cancer	0.00406	0.0176	CbGeAlD
Ixabepilone—TUBB2A—vagina—urinary bladder cancer	0.00404	0.0176	CbGeAlD
Ixabepilone—TUBB6—vagina—urinary bladder cancer	0.00399	0.0173	CbGeAlD
Ixabepilone—TUBB4B—female reproductive system—urinary bladder cancer	0.00383	0.0166	CbGeAlD
Ixabepilone—TUBB—Azacitidine—Gemcitabine—urinary bladder cancer	0.00357	0.296	CbGdCrCtD
Ixabepilone—TUBB4B—vagina—urinary bladder cancer	0.00346	0.0151	CbGeAlD
Ixabepilone—TUBB4A—lymph node—urinary bladder cancer	0.00287	0.0125	CbGeAlD
Ixabepilone—TUBB2B—lymph node—urinary bladder cancer	0.00278	0.0121	CbGeAlD
Ixabepilone—TUBB—lymph node—urinary bladder cancer	0.00263	0.0114	CbGeAlD
Ixabepilone—TUBB2A—lymph node—urinary bladder cancer	0.00261	0.0114	CbGeAlD
Ixabepilone—TUBB6—lymph node—urinary bladder cancer	0.00258	0.0112	CbGeAlD
Ixabepilone—TUBB4B—lymph node—urinary bladder cancer	0.00224	0.00973	CbGeAlD
Ixabepilone—CYP3A4—renal system—urinary bladder cancer	0.00197	0.00854	CbGeAlD
Ixabepilone—CYP3A4—female reproductive system—urinary bladder cancer	0.00157	0.00684	CbGeAlD
Ixabepilone—TUBB6—Azacitidine—Gemcitabine—urinary bladder cancer	0.00148	0.122	CbGdCrCtD
Ixabepilone—TUBB2A—Signaling events mediated by HDAC Class III—CREBBP—urinary bladder cancer	0.0011	0.0107	CbGpPWpGaD
Ixabepilone—TUBB—Parkin-Ubiquitin Proteasomal System pathway—CCNE1—urinary bladder cancer	0.00109	0.0106	CbGpPWpGaD
Ixabepilone—CYP3A4—Oxidation by Cytochrome P450—POR—urinary bladder cancer	0.00108	0.0105	CbGpPWpGaD
Ixabepilone—TUBB3—Parkin-Ubiquitin Proteasomal System pathway—CCNE1—urinary bladder cancer	0.00106	0.0104	CbGpPWpGaD
Ixabepilone—TUBB2A—Parkin-Ubiquitin Proteasomal System pathway—CCNE1—urinary bladder cancer	0.00103	0.01	CbGpPWpGaD
Ixabepilone—TUBB1—Parkin-Ubiquitin Proteasomal System pathway—CCNE1—urinary bladder cancer	0.00101	0.00982	CbGpPWpGaD
Ixabepilone—CYP3A4—Aflatoxin B1 metabolism—GSTM1—urinary bladder cancer	0.000948	0.00925	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—SMC1B—urinary bladder cancer	0.000931	0.00908	CbGpPWpGaD
Ixabepilone—TUBB4A—Parkin-Ubiquitin Proteasomal System pathway—CCNE1—urinary bladder cancer	0.000904	0.00882	CbGpPWpGaD
Ixabepilone—TUBB2B—Pathogenic Escherichia coli infection—CDH1—urinary bladder cancer	0.000886	0.00864	CbGpPWpGaD
Ixabepilone—TUBB6—Pathogenic Escherichia coli infection—CDH1—urinary bladder cancer	0.000886	0.00864	CbGpPWpGaD
Ixabepilone—TUBB—Pathogenic Escherichia coli infection—CDH1—urinary bladder cancer	0.000878	0.00856	CbGpPWpGaD
Ixabepilone—TUBB3—Pathogenic Escherichia coli infection—CDH1—urinary bladder cancer	0.000856	0.00835	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—SMC1B—urinary bladder cancer	0.000852	0.00831	CbGpPWpGaD
Ixabepilone—TUBB2A—Pathogenic Escherichia coli infection—CDH1—urinary bladder cancer	0.000829	0.00808	CbGpPWpGaD
Ixabepilone—TUBB4B—Parkin-Ubiquitin Proteasomal System pathway—CCNE1—urinary bladder cancer	0.000827	0.00807	CbGpPWpGaD
Ixabepilone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.000815	0.00795	CbGpPWpGaD
Ixabepilone—TUBB1—Pathogenic Escherichia coli infection—CDH1—urinary bladder cancer	0.00081	0.0079	CbGpPWpGaD
Ixabepilone—TUBB6—Pathogenic Escherichia coli infection—RHOA—urinary bladder cancer	0.000807	0.00788	CbGpPWpGaD
Ixabepilone—TUBB2B—Pathogenic Escherichia coli infection—RHOA—urinary bladder cancer	0.000807	0.00788	CbGpPWpGaD
Ixabepilone—TUBB—Pathogenic Escherichia coli infection—RHOA—urinary bladder cancer	0.0008	0.00781	CbGpPWpGaD
Ixabepilone—TUBB2A—Signaling events mediated by HDAC Class III—CDKN1A—urinary bladder cancer	0.000787	0.00767	CbGpPWpGaD
Ixabepilone—TUBB3—Pathogenic Escherichia coli infection—RHOA—urinary bladder cancer	0.00078	0.00761	CbGpPWpGaD
Ixabepilone—TUBB2A—Pathogenic Escherichia coli infection—RHOA—urinary bladder cancer	0.000755	0.00737	CbGpPWpGaD
Ixabepilone—TUBB2A—Signaling events mediated by HDAC Class III—EP300—urinary bladder cancer	0.000748	0.0073	CbGpPWpGaD
Ixabepilone—TUBB1—Pathogenic Escherichia coli infection—RHOA—urinary bladder cancer	0.000738	0.0072	CbGpPWpGaD
Ixabepilone—TUBB4A—Pathogenic Escherichia coli infection—CDH1—urinary bladder cancer	0.000727	0.0071	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000703	0.00685	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000703	0.00685	CbGpPWpGaD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000679	0.00662	CbGpPWpGaD
Ixabepilone—TUBB4B—Pathogenic Escherichia coli infection—CDH1—urinary bladder cancer	0.000665	0.00649	CbGpPWpGaD
Ixabepilone—TUBB4A—Pathogenic Escherichia coli infection—RHOA—urinary bladder cancer	0.000663	0.00647	CbGpPWpGaD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000657	0.00641	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—ESPL1—urinary bladder cancer	0.000643	0.00628	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000643	0.00627	CbGpPWpGaD
Ixabepilone—TUBB4B—Pathogenic Escherichia coli infection—RHOA—urinary bladder cancer	0.000606	0.00592	CbGpPWpGaD
Ixabepilone—CYP3A4—Estrogen metabolism—NQO1—urinary bladder cancer	0.000581	0.00567	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000577	0.00563	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—ESPL1—urinary bladder cancer	0.000575	0.00561	CbGpPWpGaD
Ixabepilone—TUBB6—Orphan transporters—CREBBP—urinary bladder cancer	0.000536	0.00523	CbGpPWpGaD
Ixabepilone—TUBB2B—Orphan transporters—CREBBP—urinary bladder cancer	0.000536	0.00523	CbGpPWpGaD
Ixabepilone—TUBB2A—Signaling events mediated by HDAC Class III—TP53—urinary bladder cancer	0.000536	0.00523	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—ESPL1—urinary bladder cancer	0.000533	0.0052	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000528	0.00515	CbGpPWpGaD
Ixabepilone—TUBB3—Orphan transporters—CREBBP—urinary bladder cancer	0.000518	0.00505	CbGpPWpGaD
Ixabepilone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.000517	0.00505	CbGpPWpGaD
Ixabepilone—CYP3A4—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.000511	0.00498	CbGpPWpGaD
Ixabepilone—Infestation NOS—Methotrexate—urinary bladder cancer	0.00051	0.000779	CcSEcCtD
Ixabepilone—Infestation—Methotrexate—urinary bladder cancer	0.00051	0.000779	CcSEcCtD
Ixabepilone—Pancytopenia—Epirubicin—urinary bladder cancer	0.000509	0.000776	CcSEcCtD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000508	0.00495	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000508	0.00495	CbGpPWpGaD
Ixabepilone—Hypotension—Etoposide—urinary bladder cancer	0.000508	0.000775	CcSEcCtD
Ixabepilone—Gastritis—Doxorubicin—urinary bladder cancer	0.000507	0.000774	CcSEcCtD
Ixabepilone—Pain—Cisplatin—urinary bladder cancer	0.000507	0.000774	CcSEcCtD
Ixabepilone—Muscular weakness—Doxorubicin—urinary bladder cancer	0.000506	0.000772	CcSEcCtD
Ixabepilone—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000503	0.000768	CcSEcCtD
Ixabepilone—Renal failure—Methotrexate—urinary bladder cancer	0.000502	0.000765	CcSEcCtD
Ixabepilone—TUBB2A—Orphan transporters—CREBBP—urinary bladder cancer	0.000501	0.00489	CbGpPWpGaD
Ixabepilone—Neutropenia—Epirubicin—urinary bladder cancer	0.000501	0.000764	CcSEcCtD
Ixabepilone—Dizziness—Thiotepa—urinary bladder cancer	0.0005	0.000763	CcSEcCtD
Ixabepilone—Upper respiratory tract infection—Epirubicin—urinary bladder cancer	0.000498	0.00076	CcSEcCtD
Ixabepilone—Stomatitis—Methotrexate—urinary bladder cancer	0.000497	0.000759	CcSEcCtD
Ixabepilone—Dysphagia—Doxorubicin—urinary bladder cancer	0.000495	0.000756	CcSEcCtD
Ixabepilone—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000494	0.000755	CcSEcCtD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000491	0.00479	CbGpPWpGaD
Ixabepilone—TUBB1—Orphan transporters—CREBBP—urinary bladder cancer	0.00049	0.00478	CbGpPWpGaD
Ixabepilone—Paraesthesia—Etoposide—urinary bladder cancer	0.000488	0.000744	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—ESPL1—urinary bladder cancer	0.000488	0.00476	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—STAG2—urinary bladder cancer	0.000488	0.00476	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—LIG1—urinary bladder cancer	0.000488	0.00476	CbGpPWpGaD
Ixabepilone—Weight decreased—Epirubicin—urinary bladder cancer	0.000484	0.000739	CcSEcCtD
Ixabepilone—Dyspnoea—Etoposide—urinary bladder cancer	0.000484	0.000739	CcSEcCtD
Ixabepilone—Angina pectoris—Doxorubicin—urinary bladder cancer	0.000483	0.000737	CcSEcCtD
Ixabepilone—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000483	0.000736	CcSEcCtD
Ixabepilone—Vomiting—Thiotepa—urinary bladder cancer	0.000481	0.000734	CcSEcCtD
Ixabepilone—Pneumonia—Epirubicin—urinary bladder cancer	0.00048	0.000733	CcSEcCtD
Ixabepilone—Infestation NOS—Epirubicin—urinary bladder cancer	0.000477	0.000729	CcSEcCtD
Ixabepilone—Infestation—Epirubicin—urinary bladder cancer	0.000477	0.000729	CcSEcCtD
Ixabepilone—Rash—Thiotepa—urinary bladder cancer	0.000477	0.000728	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—ESPL1—urinary bladder cancer	0.000477	0.00465	CbGpPWpGaD
Ixabepilone—Dermatitis—Thiotepa—urinary bladder cancer	0.000476	0.000727	CcSEcCtD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000475	0.00463	CbGpPWpGaD
Ixabepilone—Headache—Thiotepa—urinary bladder cancer	0.000474	0.000723	CcSEcCtD
Ixabepilone—Decreased appetite—Etoposide—urinary bladder cancer	0.000472	0.000721	CcSEcCtD
Ixabepilone—Pancytopenia—Doxorubicin—urinary bladder cancer	0.000471	0.000718	CcSEcCtD
Ixabepilone—Renal failure—Epirubicin—urinary bladder cancer	0.000469	0.000716	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000469	0.000716	CcSEcCtD
Ixabepilone—Body temperature increased—Cisplatin—urinary bladder cancer	0.000469	0.000715	CcSEcCtD
Ixabepilone—Fatigue—Etoposide—urinary bladder cancer	0.000468	0.000715	CcSEcCtD
Ixabepilone—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.000468	0.000714	CcSEcCtD
Ixabepilone—Stomatitis—Epirubicin—urinary bladder cancer	0.000465	0.00071	CcSEcCtD
Ixabepilone—Jaundice—Epirubicin—urinary bladder cancer	0.000465	0.00071	CcSEcCtD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000465	0.00453	CbGpPWpGaD
Ixabepilone—Constipation—Etoposide—urinary bladder cancer	0.000465	0.000709	CcSEcCtD
Ixabepilone—Pain—Etoposide—urinary bladder cancer	0.000465	0.000709	CcSEcCtD
Ixabepilone—Urinary tract infection—Epirubicin—urinary bladder cancer	0.000464	0.000708	CcSEcCtD
Ixabepilone—Neutropenia—Doxorubicin—urinary bladder cancer	0.000463	0.000707	CcSEcCtD
Ixabepilone—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000461	0.000703	CcSEcCtD
Ixabepilone—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.00046	0.000703	CcSEcCtD
Ixabepilone—Haemoglobin—Methotrexate—urinary bladder cancer	0.00046	0.000703	CcSEcCtD
Ixabepilone—Haemorrhage—Methotrexate—urinary bladder cancer	0.000458	0.000699	CcSEcCtD
Ixabepilone—Asthenia—Gemcitabine—urinary bladder cancer	0.000456	0.000697	CcSEcCtD
Ixabepilone—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000452	0.00069	CcSEcCtD
Ixabepilone—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000452	0.000689	CcSEcCtD
Ixabepilone—Pruritus—Gemcitabine—urinary bladder cancer	0.00045	0.000687	CcSEcCtD
Ixabepilone—Nausea—Thiotepa—urinary bladder cancer	0.000449	0.000686	CcSEcCtD
Ixabepilone—Urethral disorder—Methotrexate—urinary bladder cancer	0.000449	0.000685	CcSEcCtD
Ixabepilone—Weight decreased—Doxorubicin—urinary bladder cancer	0.000448	0.000684	CcSEcCtD
Ixabepilone—CYP3A4—Estrogen metabolism—GSTM1—urinary bladder cancer	0.000445	0.00435	CbGpPWpGaD
Ixabepilone—Pneumonia—Doxorubicin—urinary bladder cancer	0.000444	0.000678	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000444	0.000678	CcSEcCtD
Ixabepilone—Pruritus—Fluorouracil—urinary bladder cancer	0.000443	0.000675	CcSEcCtD
Ixabepilone—TUBB6—Metabolism of proteins—CDX2—urinary bladder cancer	0.000443	0.00432	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—CDX2—urinary bladder cancer	0.000443	0.00432	CbGpPWpGaD
Ixabepilone—Infestation NOS—Doxorubicin—urinary bladder cancer	0.000442	0.000674	CcSEcCtD
Ixabepilone—Infestation—Doxorubicin—urinary bladder cancer	0.000442	0.000674	CcSEcCtD
Ixabepilone—TUBB4A—Orphan transporters—CREBBP—urinary bladder cancer	0.00044	0.00429	CbGpPWpGaD
Ixabepilone—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000437	0.000667	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle—ESPL1—urinary bladder cancer	0.000436	0.00425	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—LIG1—urinary bladder cancer	0.000436	0.00425	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—STAG2—urinary bladder cancer	0.000436	0.00425	CbGpPWpGaD
Ixabepilone—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000435	0.000664	CcSEcCtD
Ixabepilone—Renal failure—Doxorubicin—urinary bladder cancer	0.000434	0.000663	CcSEcCtD
Ixabepilone—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000433	0.000661	CcSEcCtD
Ixabepilone—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000433	0.000661	CcSEcCtD
Ixabepilone—Haemoglobin—Epirubicin—urinary bladder cancer	0.000431	0.000657	CcSEcCtD
Ixabepilone—Stomatitis—Doxorubicin—urinary bladder cancer	0.000431	0.000657	CcSEcCtD
Ixabepilone—Jaundice—Doxorubicin—urinary bladder cancer	0.000431	0.000657	CcSEcCtD
Ixabepilone—Body temperature increased—Etoposide—urinary bladder cancer	0.000429	0.000655	CcSEcCtD
Ixabepilone—Abdominal pain—Etoposide—urinary bladder cancer	0.000429	0.000655	CcSEcCtD
Ixabepilone—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000429	0.000655	CcSEcCtD
Ixabepilone—Haemorrhage—Epirubicin—urinary bladder cancer	0.000429	0.000654	CcSEcCtD
Ixabepilone—Eye disorder—Methotrexate—urinary bladder cancer	0.000428	0.000653	CcSEcCtD
Ixabepilone—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000428	0.000653	CcSEcCtD
Ixabepilone—TUBB3—Metabolism of proteins—CDX2—urinary bladder cancer	0.000427	0.00417	CbGpPWpGaD
Ixabepilone—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000426	0.000651	CcSEcCtD
Ixabepilone—Asthenia—Cisplatin—urinary bladder cancer	0.000425	0.000649	CcSEcCtD
Ixabepilone—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000425	0.000649	CcSEcCtD
Ixabepilone—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000423	0.000646	CcSEcCtD
Ixabepilone—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000421	0.000643	CcSEcCtD
Ixabepilone—Urethral disorder—Epirubicin—urinary bladder cancer	0.00042	0.000641	CcSEcCtD
Ixabepilone—CYP3A4—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000419	0.00409	CbGpPWpGaD
Ixabepilone—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000418	0.000638	CcSEcCtD
Ixabepilone—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000418	0.00408	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000417	0.00407	CbGpPWpGaD
Ixabepilone—Angiopathy—Methotrexate—urinary bladder cancer	0.000416	0.000634	CcSEcCtD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000414	0.00404	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000414	0.00404	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—CDX2—urinary bladder cancer	0.000414	0.00404	CbGpPWpGaD
Ixabepilone—Immune system disorder—Methotrexate—urinary bladder cancer	0.000414	0.000631	CcSEcCtD
Ixabepilone—Dizziness—Fluorouracil—urinary bladder cancer	0.000414	0.000631	CcSEcCtD
Ixabepilone—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000413	0.00063	CcSEcCtD
Ixabepilone—Chills—Methotrexate—urinary bladder cancer	0.000411	0.000627	CcSEcCtD
Ixabepilone—Diarrhoea—Cisplatin—urinary bladder cancer	0.000406	0.000619	CcSEcCtD
Ixabepilone—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000405	0.000619	CcSEcCtD
Ixabepilone—TUBB1—Metabolism of proteins—CDX2—urinary bladder cancer	0.000405	0.00395	CbGpPWpGaD
Ixabepilone—Alopecia—Methotrexate—urinary bladder cancer	0.000405	0.000618	CcSEcCtD
Ixabepilone—Vomiting—Gemcitabine—urinary bladder cancer	0.000404	0.000617	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—STAG2—urinary bladder cancer	0.000404	0.00394	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—LIG1—urinary bladder cancer	0.000404	0.00394	CbGpPWpGaD
Ixabepilone—TUBB4B—Orphan transporters—CREBBP—urinary bladder cancer	0.000403	0.00393	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—RRM2—urinary bladder cancer	0.000402	0.00392	CbGpPWpGaD
Ixabepilone—Mental disorder—Methotrexate—urinary bladder cancer	0.000401	0.000612	CcSEcCtD
Ixabepilone—Rash—Gemcitabine—urinary bladder cancer	0.000401	0.000612	CcSEcCtD
Ixabepilone—Dermatitis—Gemcitabine—urinary bladder cancer	0.000401	0.000612	CcSEcCtD
Ixabepilone—Eye disorder—Epirubicin—urinary bladder cancer	0.000401	0.000611	CcSEcCtD
Ixabepilone—Hypersensitivity—Etoposide—urinary bladder cancer	0.0004	0.000611	CcSEcCtD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.0004	0.0039	CbGpPWpGaD
Ixabepilone—Malnutrition—Methotrexate—urinary bladder cancer	0.000399	0.000609	CcSEcCtD
Ixabepilone—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000399	0.000608	CcSEcCtD
Ixabepilone—Headache—Gemcitabine—urinary bladder cancer	0.000399	0.000608	CcSEcCtD
Ixabepilone—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000398	0.000607	CcSEcCtD
Ixabepilone—Vomiting—Fluorouracil—urinary bladder cancer	0.000398	0.000607	CcSEcCtD
Ixabepilone—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000397	0.000605	CcSEcCtD
Ixabepilone—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000395	0.000602	CcSEcCtD
Ixabepilone—Rash—Fluorouracil—urinary bladder cancer	0.000394	0.000602	CcSEcCtD
Ixabepilone—Dermatitis—Fluorouracil—urinary bladder cancer	0.000394	0.000601	CcSEcCtD
Ixabepilone—Headache—Fluorouracil—urinary bladder cancer	0.000392	0.000598	CcSEcCtD
Ixabepilone—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000392	0.000598	CcSEcCtD
Ixabepilone—Asthenia—Etoposide—urinary bladder cancer	0.00039	0.000595	CcSEcCtD
Ixabepilone—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.00039	0.000595	CcSEcCtD
Ixabepilone—Angiopathy—Epirubicin—urinary bladder cancer	0.000389	0.000594	CcSEcCtD
Ixabepilone—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000389	0.000593	CcSEcCtD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000387	0.00378	CbGpPWpGaD
Ixabepilone—Immune system disorder—Epirubicin—urinary bladder cancer	0.000387	0.000591	CcSEcCtD
Ixabepilone—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000386	0.00059	CcSEcCtD
Ixabepilone—Chills—Epirubicin—urinary bladder cancer	0.000385	0.000587	CcSEcCtD
Ixabepilone—Pruritus—Etoposide—urinary bladder cancer	0.000384	0.000587	CcSEcCtD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000381	0.00372	CbGpPWpGaD
Ixabepilone—Alopecia—Epirubicin—urinary bladder cancer	0.000379	0.000578	CcSEcCtD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000379	0.00369	CbGpPWpGaD
Ixabepilone—Nausea—Gemcitabine—urinary bladder cancer	0.000378	0.000577	CcSEcCtD
Ixabepilone—Vomiting—Cisplatin—urinary bladder cancer	0.000377	0.000575	CcSEcCtD
Ixabepilone—Mental disorder—Epirubicin—urinary bladder cancer	0.000376	0.000573	CcSEcCtD
Ixabepilone—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000375	0.000572	CcSEcCtD
Ixabepilone—Rash—Cisplatin—urinary bladder cancer	0.000374	0.000571	CcSEcCtD
Ixabepilone—Dermatitis—Cisplatin—urinary bladder cancer	0.000374	0.00057	CcSEcCtD
Ixabepilone—Malnutrition—Epirubicin—urinary bladder cancer	0.000373	0.000569	CcSEcCtD
Ixabepilone—Diarrhoea—Etoposide—urinary bladder cancer	0.000372	0.000567	CcSEcCtD
Ixabepilone—Nausea—Fluorouracil—urinary bladder cancer	0.000372	0.000567	CcSEcCtD
Ixabepilone—Eye disorder—Doxorubicin—urinary bladder cancer	0.000371	0.000566	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—STAG2—urinary bladder cancer	0.00037	0.0036	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—LIG1—urinary bladder cancer	0.00037	0.0036	CbGpPWpGaD
Ixabepilone—Anaemia—Methotrexate—urinary bladder cancer	0.000369	0.000562	CcSEcCtD
Ixabepilone—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000368	0.000562	CcSEcCtD
Ixabepilone—TUBB4A—Metabolism of proteins—CDX2—urinary bladder cancer	0.000363	0.00355	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—STAG2—urinary bladder cancer	0.000361	0.00352	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—LIG1—urinary bladder cancer	0.000361	0.00352	CbGpPWpGaD
Ixabepilone—Angiopathy—Doxorubicin—urinary bladder cancer	0.00036	0.000549	CcSEcCtD
Ixabepilone—Dizziness—Etoposide—urinary bladder cancer	0.000359	0.000548	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—RRM2—urinary bladder cancer	0.000359	0.0035	CbGpPWpGaD
Ixabepilone—Muscle spasms—Epirubicin—urinary bladder cancer	0.000359	0.000547	CcSEcCtD
Ixabepilone—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000358	0.000547	CcSEcCtD
Ixabepilone—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000357	0.000546	CcSEcCtD
Ixabepilone—Leukopenia—Methotrexate—urinary bladder cancer	0.000357	0.000545	CcSEcCtD
Ixabepilone—Chills—Doxorubicin—urinary bladder cancer	0.000356	0.000543	CcSEcCtD
Ixabepilone—Nausea—Cisplatin—urinary bladder cancer	0.000352	0.000538	CcSEcCtD
Ixabepilone—Alopecia—Doxorubicin—urinary bladder cancer	0.00035	0.000535	CcSEcCtD
Ixabepilone—Cough—Methotrexate—urinary bladder cancer	0.000348	0.000531	CcSEcCtD
Ixabepilone—Mental disorder—Doxorubicin—urinary bladder cancer	0.000347	0.00053	CcSEcCtD
Ixabepilone—Vomiting—Etoposide—urinary bladder cancer	0.000345	0.000527	CcSEcCtD
Ixabepilone—Malnutrition—Doxorubicin—urinary bladder cancer	0.000345	0.000527	CcSEcCtD
Ixabepilone—Anaemia—Epirubicin—urinary bladder cancer	0.000345	0.000526	CcSEcCtD
Ixabepilone—Rash—Etoposide—urinary bladder cancer	0.000343	0.000523	CcSEcCtD
Ixabepilone—Dermatitis—Etoposide—urinary bladder cancer	0.000342	0.000522	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle, Mitotic—SMC1A—urinary bladder cancer	0.000341	0.00333	CbGpPWpGaD
Ixabepilone—Headache—Etoposide—urinary bladder cancer	0.00034	0.000519	CcSEcCtD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.00034	0.00332	CbGpPWpGaD
Ixabepilone—Chest pain—Methotrexate—urinary bladder cancer	0.000339	0.000518	CcSEcCtD
Ixabepilone—Arthralgia—Methotrexate—urinary bladder cancer	0.000339	0.000518	CcSEcCtD
Ixabepilone—Myalgia—Methotrexate—urinary bladder cancer	0.000339	0.000518	CcSEcCtD
Ixabepilone—TUBB—G2/M Transition—EP300—urinary bladder cancer	0.000339	0.0033	CbGpPWpGaD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000337	0.000514	CcSEcCtD
Ixabepilone—Syncope—Epirubicin—urinary bladder cancer	0.000335	0.000511	CcSEcCtD
Ixabepilone—Leukopenia—Epirubicin—urinary bladder cancer	0.000334	0.00051	CcSEcCtD
Ixabepilone—TUBB—Mitotic G2-G2/M phases—EP300—urinary bladder cancer	0.000334	0.00326	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—RRM2—urinary bladder cancer	0.000333	0.00325	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—CDX2—urinary bladder cancer	0.000332	0.00324	CbGpPWpGaD
Ixabepilone—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000332	0.000507	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle—STAG2—urinary bladder cancer	0.00033	0.00322	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—LIG1—urinary bladder cancer	0.00033	0.00322	CbGpPWpGaD
Ixabepilone—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000328	0.000501	CcSEcCtD
Ixabepilone—Cough—Epirubicin—urinary bladder cancer	0.000326	0.000497	CcSEcCtD
Ixabepilone—Infection—Methotrexate—urinary bladder cancer	0.000323	0.000493	CcSEcCtD
Ixabepilone—Nausea—Etoposide—urinary bladder cancer	0.000323	0.000492	CcSEcCtD
Ixabepilone—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000319	0.000487	CcSEcCtD
Ixabepilone—Anaemia—Doxorubicin—urinary bladder cancer	0.000319	0.000487	CcSEcCtD
Ixabepilone—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000319	0.000486	CcSEcCtD
Ixabepilone—Arthralgia—Epirubicin—urinary bladder cancer	0.000318	0.000485	CcSEcCtD
Ixabepilone—Myalgia—Epirubicin—urinary bladder cancer	0.000318	0.000485	CcSEcCtD
Ixabepilone—Chest pain—Epirubicin—urinary bladder cancer	0.000318	0.000485	CcSEcCtD
Ixabepilone—Skin disorder—Methotrexate—urinary bladder cancer	0.000316	0.000482	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000315	0.000481	CcSEcCtD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000311	0.00303	CbGpPWpGaD
Ixabepilone—Anorexia—Methotrexate—urinary bladder cancer	0.00031	0.000473	CcSEcCtD
Ixabepilone—Syncope—Doxorubicin—urinary bladder cancer	0.00031	0.000473	CcSEcCtD
Ixabepilone—Leukopenia—Doxorubicin—urinary bladder cancer	0.000309	0.000472	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—SMC1A—urinary bladder cancer	0.000305	0.00298	CbGpPWpGaD
Ixabepilone—Oedema—Epirubicin—urinary bladder cancer	0.000305	0.000465	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—RRM2—urinary bladder cancer	0.000304	0.00297	CbGpPWpGaD
Ixabepilone—Hypotension—Methotrexate—urinary bladder cancer	0.000304	0.000464	CcSEcCtD
Ixabepilone—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000303	0.000463	CcSEcCtD
Ixabepilone—Infection—Epirubicin—urinary bladder cancer	0.000303	0.000462	CcSEcCtD
Ixabepilone—Cough—Doxorubicin—urinary bladder cancer	0.000301	0.00046	CcSEcCtD
Ixabepilone—Shock—Epirubicin—urinary bladder cancer	0.0003	0.000457	CcSEcCtD
Ixabepilone—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000299	0.000456	CcSEcCtD
Ixabepilone—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000298	0.000455	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—RRM2—urinary bladder cancer	0.000297	0.0029	CbGpPWpGaD
Ixabepilone—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000296	0.000452	CcSEcCtD
Ixabepilone—Skin disorder—Epirubicin—urinary bladder cancer	0.000296	0.000451	CcSEcCtD
Ixabepilone—Insomnia—Methotrexate—urinary bladder cancer	0.000294	0.000449	CcSEcCtD
Ixabepilone—Chest pain—Doxorubicin—urinary bladder cancer	0.000294	0.000449	CcSEcCtD
Ixabepilone—Myalgia—Doxorubicin—urinary bladder cancer	0.000294	0.000449	CcSEcCtD
Ixabepilone—Arthralgia—Doxorubicin—urinary bladder cancer	0.000294	0.000449	CcSEcCtD
Ixabepilone—Paraesthesia—Methotrexate—urinary bladder cancer	0.000292	0.000446	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000292	0.000445	CcSEcCtD
Ixabepilone—Anorexia—Epirubicin—urinary bladder cancer	0.00029	0.000443	CcSEcCtD
Ixabepilone—Dyspnoea—Methotrexate—urinary bladder cancer	0.00029	0.000443	CcSEcCtD
Ixabepilone—CYP3A4—Biological oxidations—GSTZ1—urinary bladder cancer	0.000285	0.00278	CbGpPWpGaD
Ixabepilone—Hypotension—Epirubicin—urinary bladder cancer	0.000285	0.000434	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—SMC1A—urinary bladder cancer	0.000283	0.00276	CbGpPWpGaD
Ixabepilone—Decreased appetite—Methotrexate—urinary bladder cancer	0.000283	0.000432	CcSEcCtD
Ixabepilone—Oedema—Doxorubicin—urinary bladder cancer	0.000282	0.00043	CcSEcCtD
Ixabepilone—CYP3A4—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000281	0.00275	CbGpPWpGaD
Ixabepilone—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000281	0.000429	CcSEcCtD
Ixabepilone—TUBB4A—G2/M Transition—EP300—urinary bladder cancer	0.000281	0.00274	CbGpPWpGaD
Ixabepilone—Fatigue—Methotrexate—urinary bladder cancer	0.000281	0.000428	CcSEcCtD
Ixabepilone—Infection—Doxorubicin—urinary bladder cancer	0.00028	0.000427	CcSEcCtD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.00028	0.00273	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.00028	0.00273	CbGpPWpGaD
Ixabepilone—Pain—Methotrexate—urinary bladder cancer	0.000278	0.000425	CcSEcCtD
Ixabepilone—TUBB6—Metabolism of proteins—IGFBP3—urinary bladder cancer	0.000278	0.00271	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—IGFBP3—urinary bladder cancer	0.000278	0.00271	CbGpPWpGaD
Ixabepilone—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000277	0.000423	CcSEcCtD
Ixabepilone—Shock—Doxorubicin—urinary bladder cancer	0.000277	0.000423	CcSEcCtD
Ixabepilone—TUBB4A—Mitotic G2-G2/M phases—EP300—urinary bladder cancer	0.000277	0.0027	CbGpPWpGaD
Ixabepilone—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000276	0.000422	CcSEcCtD
Ixabepilone—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000276	0.000421	CcSEcCtD
Ixabepilone—Insomnia—Epirubicin—urinary bladder cancer	0.000275	0.00042	CcSEcCtD
Ixabepilone—Skin disorder—Doxorubicin—urinary bladder cancer	0.000274	0.000418	CcSEcCtD
Ixabepilone—Paraesthesia—Epirubicin—urinary bladder cancer	0.000273	0.000417	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle—RRM2—urinary bladder cancer	0.000272	0.00265	CbGpPWpGaD
Ixabepilone—Dyspnoea—Epirubicin—urinary bladder cancer	0.000271	0.000414	CcSEcCtD
Ixabepilone—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	0.000271	0.00264	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	0.000271	0.00264	CbGpPWpGaD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.00027	0.00264	CbGpPWpGaD
Ixabepilone—Anorexia—Doxorubicin—urinary bladder cancer	0.000269	0.00041	CcSEcCtD
Ixabepilone—TUBB3—Metabolism of proteins—IGFBP3—urinary bladder cancer	0.000268	0.00262	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000267	0.0026	CbGpPWpGaD
Ixabepilone—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000266	0.000406	CcSEcCtD
Ixabepilone—Decreased appetite—Epirubicin—urinary bladder cancer	0.000265	0.000404	CcSEcCtD
Ixabepilone—Hypotension—Doxorubicin—urinary bladder cancer	0.000263	0.000402	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000263	0.000401	CcSEcCtD
Ixabepilone—Fatigue—Epirubicin—urinary bladder cancer	0.000263	0.000401	CcSEcCtD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000262	0.00255	CbGpPWpGaD
Ixabepilone—Constipation—Epirubicin—urinary bladder cancer	0.00026	0.000397	CcSEcCtD
Ixabepilone—Pain—Epirubicin—urinary bladder cancer	0.00026	0.000397	CcSEcCtD
Ixabepilone—TUBB2A—Metabolism of proteins—IGFBP3—urinary bladder cancer	0.00026	0.00254	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—SMC1A—urinary bladder cancer	0.000259	0.00252	CbGpPWpGaD
Ixabepilone—Abdominal pain—Methotrexate—urinary bladder cancer	0.000257	0.000393	CcSEcCtD
Ixabepilone—Body temperature increased—Methotrexate—urinary bladder cancer	0.000257	0.000393	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000257	0.000392	CcSEcCtD
Ixabepilone—TUBB4B—G2/M Transition—EP300—urinary bladder cancer	0.000257	0.0025	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000256	0.0025	CbGpPWpGaD
Ixabepilone—Insomnia—Doxorubicin—urinary bladder cancer	0.000255	0.000389	CcSEcCtD
Ixabepilone—TUBB1—Metabolism of proteins—IGFBP3—urinary bladder cancer	0.000254	0.00248	CbGpPWpGaD
Ixabepilone—TUBB4B—Mitotic G2-G2/M phases—EP300—urinary bladder cancer	0.000253	0.00247	CbGpPWpGaD
Ixabepilone—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000253	0.000386	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—SMC1A—urinary bladder cancer	0.000253	0.00247	CbGpPWpGaD
Ixabepilone—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000251	0.000383	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000249	0.00038	CcSEcCtD
Ixabepilone—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	0.000247	0.00241	CbGpPWpGaD
Ixabepilone—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000245	0.000374	CcSEcCtD
Ixabepilone—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000244	0.00238	CbGpPWpGaD
Ixabepilone—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000243	0.000371	CcSEcCtD
Ixabepilone—Fatigue—Doxorubicin—urinary bladder cancer	0.000243	0.000371	CcSEcCtD
Ixabepilone—Constipation—Doxorubicin—urinary bladder cancer	0.000241	0.000368	CcSEcCtD
Ixabepilone—Pain—Doxorubicin—urinary bladder cancer	0.000241	0.000368	CcSEcCtD
Ixabepilone—Body temperature increased—Epirubicin—urinary bladder cancer	0.000241	0.000367	CcSEcCtD
Ixabepilone—Abdominal pain—Epirubicin—urinary bladder cancer	0.000241	0.000367	CcSEcCtD
Ixabepilone—Hypersensitivity—Methotrexate—urinary bladder cancer	0.00024	0.000366	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle, Mitotic—CCNE1—urinary bladder cancer	0.000237	0.00231	CbGpPWpGaD
Ixabepilone—Asthenia—Methotrexate—urinary bladder cancer	0.000233	0.000356	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle, Mitotic—TYMS—urinary bladder cancer	0.000232	0.00227	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—SMC1A—urinary bladder cancer	0.000231	0.00226	CbGpPWpGaD
Ixabepilone—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.00023	0.000352	CcSEcCtD
Ixabepilone—Pruritus—Methotrexate—urinary bladder cancer	0.00023	0.000351	CcSEcCtD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.00023	0.00224	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—IGFBP3—urinary bladder cancer	0.000228	0.00223	CbGpPWpGaD
Ixabepilone—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000224	0.000342	CcSEcCtD
Ixabepilone—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	0.000223	0.00217	CbGpPWpGaD
Ixabepilone—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000223	0.00034	CcSEcCtD
Ixabepilone—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000223	0.00034	CcSEcCtD
Ixabepilone—Diarrhoea—Methotrexate—urinary bladder cancer	0.000223	0.00034	CcSEcCtD
Ixabepilone—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.00022	0.00214	CbGpPWpGaD
Ixabepilone—Asthenia—Epirubicin—urinary bladder cancer	0.000218	0.000333	CcSEcCtD
Ixabepilone—Pruritus—Epirubicin—urinary bladder cancer	0.000215	0.000329	CcSEcCtD
Ixabepilone—Dizziness—Methotrexate—urinary bladder cancer	0.000215	0.000328	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—CCNE1—urinary bladder cancer	0.000212	0.00206	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.00021	0.00205	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—IGFBP3—urinary bladder cancer	0.000209	0.00204	CbGpPWpGaD
Ixabepilone—Diarrhoea—Epirubicin—urinary bladder cancer	0.000208	0.000318	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—TYMS—urinary bladder cancer	0.000208	0.00203	CbGpPWpGaD
Ixabepilone—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000208	0.000317	CcSEcCtD
Ixabepilone—Vomiting—Methotrexate—urinary bladder cancer	0.000207	0.000316	CcSEcCtD
Ixabepilone—Rash—Methotrexate—urinary bladder cancer	0.000205	0.000313	CcSEcCtD
Ixabepilone—Dermatitis—Methotrexate—urinary bladder cancer	0.000205	0.000313	CcSEcCtD
Ixabepilone—Headache—Methotrexate—urinary bladder cancer	0.000204	0.000311	CcSEcCtD
Ixabepilone—Asthenia—Doxorubicin—urinary bladder cancer	0.000202	0.000309	CcSEcCtD
Ixabepilone—Dizziness—Epirubicin—urinary bladder cancer	0.000201	0.000307	CcSEcCtD
Ixabepilone—Pruritus—Doxorubicin—urinary bladder cancer	0.000199	0.000304	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CCNE1—urinary bladder cancer	0.000196	0.00191	CbGpPWpGaD
Ixabepilone—Vomiting—Epirubicin—urinary bladder cancer	0.000194	0.000296	CcSEcCtD
Ixabepilone—Nausea—Methotrexate—urinary bladder cancer	0.000193	0.000295	CcSEcCtD
Ixabepilone—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000193	0.000294	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—TYMS—urinary bladder cancer	0.000193	0.00188	CbGpPWpGaD
Ixabepilone—Rash—Epirubicin—urinary bladder cancer	0.000192	0.000293	CcSEcCtD
Ixabepilone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000192	0.00187	CbGpPWpGaD
Ixabepilone—Dermatitis—Epirubicin—urinary bladder cancer	0.000192	0.000293	CcSEcCtD
Ixabepilone—Headache—Epirubicin—urinary bladder cancer	0.000191	0.000291	CcSEcCtD
Ixabepilone—Dizziness—Doxorubicin—urinary bladder cancer	0.000186	0.000284	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle, Mitotic—CDK4—urinary bladder cancer	0.000181	0.00177	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—TERT—urinary bladder cancer	0.000181	0.00177	CbGpPWpGaD
Ixabepilone—Nausea—Epirubicin—urinary bladder cancer	0.000181	0.000276	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CCNE1—urinary bladder cancer	0.000179	0.00175	CbGpPWpGaD
Ixabepilone—Vomiting—Doxorubicin—urinary bladder cancer	0.000179	0.000273	CcSEcCtD
Ixabepilone—Rash—Doxorubicin—urinary bladder cancer	0.000178	0.000271	CcSEcCtD
Ixabepilone—Dermatitis—Doxorubicin—urinary bladder cancer	0.000177	0.000271	CcSEcCtD
Ixabepilone—Headache—Doxorubicin—urinary bladder cancer	0.000177	0.000269	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—TYMS—urinary bladder cancer	0.000176	0.00172	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—CCNE1—urinary bladder cancer	0.000175	0.00171	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—TYMS—urinary bladder cancer	0.000172	0.00168	CbGpPWpGaD
Ixabepilone—Nausea—Doxorubicin—urinary bladder cancer	0.000167	0.000255	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—ATM—urinary bladder cancer	0.000163	0.00159	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—CDK4—urinary bladder cancer	0.000162	0.00158	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—CCNE1—urinary bladder cancer	0.00016	0.00156	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—RB1—urinary bladder cancer	0.000158	0.00154	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—TYMS—urinary bladder cancer	0.000157	0.00154	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CDK4—urinary bladder cancer	0.00015	0.00146	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—TERT—urinary bladder cancer	0.00015	0.00146	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.000148	0.00145	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000146	0.00143	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—RB1—urinary bladder cancer	0.000141	0.00137	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—CDKN2A—urinary bladder cancer	0.000139	0.00135	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CDK4—urinary bladder cancer	0.000137	0.00134	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—TERT—urinary bladder cancer	0.000137	0.00134	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—ATM—urinary bladder cancer	0.000135	0.00132	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—CDK4—urinary bladder cancer	0.000134	0.00131	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000131	0.00128	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000131	0.00128	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—RB1—urinary bladder cancer	0.000131	0.00127	CbGpPWpGaD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000126	0.00123	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—CDKN2A—urinary bladder cancer	0.000124	0.00121	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—ATM—urinary bladder cancer	0.000123	0.0012	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—CDK4—urinary bladder cancer	0.000123	0.0012	CbGpPWpGaD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000122	0.00119	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.00012	0.00117	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—RB1—urinary bladder cancer	0.000119	0.00116	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	0.000119	0.00116	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—IGF1—urinary bladder cancer	0.000117	0.00115	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—IGF1—urinary bladder cancer	0.000117	0.00115	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—CCND1—urinary bladder cancer	0.000117	0.00114	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—RB1—urinary bladder cancer	0.000117	0.00114	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	0.000115	0.00112	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CDKN2A—urinary bladder cancer	0.000115	0.00112	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—IGF1—urinary bladder cancer	0.000113	0.00111	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—CDKN1A—urinary bladder cancer	0.000113	0.0011	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—IGF1—urinary bladder cancer	0.00011	0.00107	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—EP300—urinary bladder cancer	0.000108	0.00105	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000107	0.00105	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—IGF1—urinary bladder cancer	0.000107	0.00105	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—RB1—urinary bladder cancer	0.000107	0.00104	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CDKN2A—urinary bladder cancer	0.000105	0.00102	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—CCND1—urinary bladder cancer	0.000105	0.00102	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—CDKN2A—urinary bladder cancer	0.000103	0.001	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—CDKN1A—urinary bladder cancer	0.000101	0.000987	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	9.83e-05	0.000959	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CCND1—urinary bladder cancer	9.7e-05	0.000946	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—IGF1—urinary bladder cancer	9.65e-05	0.000941	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—EP300—urinary bladder cancer	9.63e-05	0.00094	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—CXCL8—urinary bladder cancer	9.45e-05	0.000922	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—CXCL8—urinary bladder cancer	9.45e-05	0.000922	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—MYC—urinary bladder cancer	9.39e-05	0.000916	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—CDKN2A—urinary bladder cancer	9.39e-05	0.000916	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CDKN1A—urinary bladder cancer	9.38e-05	0.000915	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—CXCL8—urinary bladder cancer	9.12e-05	0.00089	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—EP300—urinary bladder cancer	8.93e-05	0.000871	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CCND1—urinary bladder cancer	8.87e-05	0.000865	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—CXCL8—urinary bladder cancer	8.84e-05	0.000862	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—IGF1—urinary bladder cancer	8.82e-05	0.000861	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—CCND1—urinary bladder cancer	8.67e-05	0.000846	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—CXCL8—urinary bladder cancer	8.64e-05	0.000843	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CDKN1A—urinary bladder cancer	8.58e-05	0.000837	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—MYC—urinary bladder cancer	8.39e-05	0.000819	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—CDKN1A—urinary bladder cancer	8.39e-05	0.000818	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—EP300—urinary bladder cancer	8.16e-05	0.000796	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—EP300—urinary bladder cancer	7.98e-05	0.000779	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	7.97e-05	0.000777	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—CCND1—urinary bladder cancer	7.93e-05	0.000774	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	7.86e-05	0.000767	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—MYC—urinary bladder cancer	7.78e-05	0.000759	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—CXCL8—urinary bladder cancer	7.76e-05	0.000757	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—CDKN1A—urinary bladder cancer	7.67e-05	0.000748	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	7.32e-05	0.000714	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—EP300—urinary bladder cancer	7.3e-05	0.000712	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	7.22e-05	0.000704	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—MYC—urinary bladder cancer	7.11e-05	0.000694	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—CXCL8—urinary bladder cancer	7.09e-05	0.000692	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—MYC—urinary bladder cancer	6.95e-05	0.000678	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—TP53—urinary bladder cancer	6.89e-05	0.000672	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—MYC—urinary bladder cancer	6.36e-05	0.00062	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—TP53—urinary bladder cancer	5.71e-05	0.000557	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—TP53—urinary bladder cancer	5.22e-05	0.00051	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	4.88e-05	0.000476	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	4.63e-05	0.000451	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—NAT1—urinary bladder cancer	4.63e-05	0.000451	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	4.23e-05	0.000413	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	3.81e-05	0.000372	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	3.6e-05	0.000351	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	3.51e-05	0.000342	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—TYMP—urinary bladder cancer	2.8e-05	0.000273	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—NAT2—urinary bladder cancer	2.54e-05	0.000247	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—RRM2—urinary bladder cancer	2.19e-05	0.000213	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ENO2—urinary bladder cancer	2.03e-05	0.000198	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	2.03e-05	0.000198	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.97e-05	0.000192	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.63e-05	0.000159	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.36e-05	0.000133	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.27e-05	0.000124	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.25e-05	0.000122	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.25e-05	0.000122	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.2e-05	0.000117	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.18e-05	0.000115	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.11e-05	0.000108	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PPARG—urinary bladder cancer	8.97e-06	8.75e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	8.62e-06	8.41e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	7.06e-06	6.89e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PTEN—urinary bladder cancer	6.16e-06	6.01e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—EP300—urinary bladder cancer	5.87e-06	5.73e-05	CbGpPWpGaD
